AU2861292A - Binding of plasmodium falciparum-infected erythrocytes to cd36 - Google Patents
Binding of plasmodium falciparum-infected erythrocytes to cd36Info
- Publication number
- AU2861292A AU2861292A AU28612/92A AU2861292A AU2861292A AU 2861292 A AU2861292 A AU 2861292A AU 28612/92 A AU28612/92 A AU 28612/92A AU 2861292 A AU2861292 A AU 2861292A AU 2861292 A AU2861292 A AU 2861292A
- Authority
- AU
- Australia
- Prior art keywords
- binding
- plasmodium falciparum
- infected erythrocytes
- erythrocytes
- infected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US862708 | 1986-05-13 | ||
US899064 | 1986-08-21 | ||
US76962591A | 1991-10-03 | 1991-10-03 | |
US769625 | 1991-10-03 | ||
US86270892A | 1992-04-03 | 1992-04-03 | |
US89906492A | 1992-06-12 | 1992-06-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2861292A true AU2861292A (en) | 1993-05-03 |
Family
ID=27419659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28612/92A Abandoned AU2861292A (en) | 1991-10-03 | 1992-10-05 | Binding of plasmodium falciparum-infected erythrocytes to cd36 |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2861292A (en) |
WO (1) | WO1993006849A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6322976B1 (en) * | 1998-05-28 | 2001-11-27 | Medical Research Council | Compositions and methods of disease diagnosis and therapy |
WO2009043525A2 (en) * | 2007-09-11 | 2009-04-09 | Mondobiotech Laboratories Ag | Use of the combination of gluten exorphin c and cd36 as a therapeutic agent |
-
1992
- 1992-10-05 WO PCT/US1992/008483 patent/WO1993006849A1/en active Application Filing
- 1992-10-05 AU AU28612/92A patent/AU2861292A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1993006849A1 (en) | 1993-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU683000B2 (en) | Improved antibodies to Plasmodium falciparum | |
EP0354379A3 (en) | Ski | |
AU3070889A (en) | Friction modified oleaginous concentrates of improved stability | |
AU6884287A (en) | Water ski binding | |
EP0356676A3 (en) | Ski binding | |
AU2797892A (en) | (plasmodium falciparum)-infected erythrocytes binding to icam-1 and cd36 | |
AU4732685A (en) | Antigens of plasmodium falciparum | |
AU2861292A (en) | Binding of plasmodium falciparum-infected erythrocytes to cd36 | |
AU3185989A (en) | Gold bath | |
GB2221919B (en) | Novel isoindoline pigments | |
EP0345453A3 (en) | Ski binding | |
EP0378859A3 (en) | Foldable ski | |
AU5103185A (en) | Musical tea kettle | |
AU2384688A (en) | Monoclonal antibodies to a plasmodium falciparum protein | |
AU637468B2 (en) | Plasmodium sporozoite antigen | |
AU7163091A (en) | Novel malarial sporozoite peptide antigens | |
EP0327367A3 (en) | Ski | |
GB9109186D0 (en) | Preparation of thionucleosides | |
GB8816465D0 (en) | Binding of basic refactories | |
AU3894889A (en) | Improvements to coasters | |
AU5095590A (en) | Basket of ski pole | |
EP0340623A3 (en) | Toe-holding ski binding | |
AU5642790A (en) | Ski lift | |
EP0336846A3 (en) | Mono-ski | |
AU7698287A (en) | Small molecular weight antigen of plasmodium falciparum |